Literature DB >> 22034501

Novel lipoprotein subfraction and size measurements in prediction of mortality in maintenance hemodialysis patients.

Nazanin Noori1, Michael P Caulfield, Wael A Salameh, Richard E Reitz, Susanne B Nicholas, Miklos Z Molnar, Allen R Nissenson, Csaba P Kovesdy, Kamyar Kalantar-Zadeh.   

Abstract

BACKGROUND AND OBJECTIVES: Conventional lipid profiles usually cannot predict cardiovascular outcomes in chronic disease states. We hypothesized that novel lipoprotein subfraction concentrations and LDL particle size measurements better predict mortality in maintenance hemodialysis (MHD) patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Mortality-predictability of LDL particle diameter and lipoprotein subfraction concentrations, measured by novel ion mobility, was examined in a cohort of 235 hemodialysis patients who were followed for up to 6 years using Cox models with adjustment for important covariables.
RESULTS: Patients were 54 ± 14 years old (mean ± SD) and included 45% women with total, LDL and HDL cholesterol levels of 143 ± 42, 76 ± 29, and 37 ± 12 mg/dl, respectively. Over 6 years, 71 patients (31%) died. Conventional lipid profile was not associated with mortality. The death hazard ratio (HR, 95% confidence interval) of the highest versus lowest quartiles of very small and large LDL particle concentrations were 2.43 (1.03 to 5.72) and 0.38 (0.15 to 0.96), respectively. Across increasing quartiles of LDL particle diameter, death HRs were 1.00, 0.93 (0.46 to 1.87), 0.43 (0.21 to 0.89), and 0.45 (0.31 to 1.00), respectively.
CONCLUSIONS: Whereas conventional lipid profile cannot predict mortality in MHD patients, larger novel LDL particle diameter or higher large LDL particle concentrations appear predictive of greater survival, whereas higher very small LDL particle concentration is associated with higher death risk. Examining lipoprotein subfraction modulation in chronic diseases is indicated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22034501      PMCID: PMC3255365          DOI: 10.2215/CJN.03650411

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  29 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

Review 3.  Low-density lipoprotein particle number and risk for cardiovascular disease.

Authors:  William C Cromwell; James D Otvos
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

4.  Flexible regression models with cubic splines.

Authors:  S Durrleman; R Simon
Journal:  Stat Med       Date:  1989-05       Impact factor: 2.373

Review 5.  Lipoprotein subspecies and risk of coronary disease.

Authors:  T A Musliner; R M Krauss
Journal:  Clin Chem       Date:  1988       Impact factor: 8.327

Review 6.  The Nutritional and Inflammatory Evaluation in Dialysis patients (NIED) study: overview of the NIED study and the role of dietitians.

Authors:  Sara Colman; Rochelle Bross; Debbie Benner; Joanne Chow; Amy Braglia; Jenia Arzaghi; Jennifer Dennis; Leslie Martinez; Delma Baylon Baldo; Vina Agarwal; Tina Trundnowski; Jennifer Zitterkoph; Brenda Martinez; Osman S Khawar; Kamyar Kalantar-Zadeh
Journal:  J Ren Nutr       Date:  2005-04       Impact factor: 3.655

7.  Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.

Authors:  Paul M Ridker; Nader Rifai; Nancy R Cook; Gary Bradwin; Julie E Buring
Journal:  JAMA       Date:  2005-07-20       Impact factor: 56.272

8.  Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities.

Authors:  E G Lowrie; N L Lew
Journal:  Am J Kidney Dis       Date:  1990-05       Impact factor: 8.860

9.  Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition.

Authors:  Yongmei Liu; Josef Coresh; Joseph A Eustace; J Craig Longenecker; Bernard Jaar; Nancy E Fink; Russell P Tracy; Neil R Powe; Michael J Klag
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

10.  Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis.

Authors:  Mehdi Rambod; Csaba P Kovesdy; Rachelle Bross; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  Am J Clin Nutr       Date:  2008-12       Impact factor: 7.045

View more
  7 in total

1.  Lipoprotein subfractions and particle size in end-stage renal disease.

Authors:  Peter A McCullough; Fawaz Al-Ejel; Robert C Maynard
Journal:  Clin J Am Soc Nephrol       Date:  2011-12       Impact factor: 8.237

2.  Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients.

Authors:  Hamid Moradi; Elani Streja; Moti L Kashyap; Nosratola D Vaziri; Gregg C Fonarow; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

3.  A Comparative Study of Lipid Profile and Cardiovascular Risk Biomarkers Among Chronic Haemodialysis Patients and Healthy Individuals.

Authors:  Shanmugam Lokesh; Tony Mathew Kadavanu; Siva Ranganathan Green; Tarun Kumar Dutta; Radhakrishnan Hemachandar; Arun Kumar Ramachandrappa; Shashank Rakesh Tiwari; Ezhumalai Govindasamy
Journal:  J Clin Diagn Res       Date:  2016-09-01

4.  HDL (High-Density Lipoprotein) Metrics and Atherosclerotic Risk in Women.

Authors:  Samar R El Khoudary; Indre Ceponiene; Saad Samargandy; James H Stein; Dong Li; Matthew C Tattersall; Matthew J Budoff
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

Review 5.  Role of HDL dysfunction in end-stage renal disease: a double-edged sword.

Authors:  Hamid Moradi; Nosratola D Vaziri; Moti L Kashyap; Hamid M Said; Kamyar Kalantar-Zadeh
Journal:  J Ren Nutr       Date:  2013-05       Impact factor: 3.655

6.  Relationship between Icodextrin use and decreased level of small low-density lipoprotein cholesterol fractioned by high-performance gel permeation chromatography.

Authors:  Eiichiro Kanda; Masumi Ai; Asami Iwamoto; Mitsuyo Okazaki; Yoshitaka Maeda; Sei Sasaki; Masayuki Yoshida
Journal:  BMC Nephrol       Date:  2013-10-26       Impact factor: 2.388

7.  Advanced lipoprotein parameters could better explain atheromatosis in non-diabetic chronic kidney disease patients.

Authors:  Marcelino Bermudez-Lopez; Hector Perpiñan; Nuria Amigo; Eva Castro; Nuria Alonso; Didac Mauricio; Elvira Fernandez; Jose M Valdivielso
Journal:  Clin Kidney J       Date:  2021-07-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.